For over 50 years, Alfa Wassermann has been providing top quality products and services to the healthcare community.  AWI's rich history proves that you can count on Alfa Wassermann for results.  Take a look at some of our key milestones:

1960

 
  Inception of Electro-Nucleonics, Inc. (ENI) to do research and development in gas centrifuge technology.  
  1969  
  ENI introduces its Model K™ ultracentrifuge, and the first centrifugal clinical chemistry blood analyzer, GEMSAEC™.  
  Electro-Nucleonics Laboratories, Inc. (ENLI) organized to apply our ultracentrifugation technology to biophysical separations.  
  1972  
  The privately financed construction of Cell Science Laboratory by ENI is completed.  
  1976  
  Introduced GEMENI®, the first clinical chemistry analyzer to bring microprocessor-based testing into the hospital.  
  1978  
  Introduced RIAUSURE II®, the automated hepatitis B test.  
  1981  
  FLEXIGEM is introduced to offer clinical chemistry testing in the mid to large hospital laboratory.  
  Princeton Biomedix is acquired from Becton Dickinson & Co. Its chemistry reagent manufacturing capability adds strength to ENI's growing position as a fully integrated supplier of medical diagnostics systems.  
  1982  
  GEMSTAR™ introduced as first profile analyzer for physicians' office testing.  
  1984  
  ENI is one of five companies selected by the FDA to develop a blood screening test for AIDS.  
  1985  
  ENI is the second company to receive a license to market its screening test for HTLV-III, the AIDS-linked virus.  
  1989  
  ENI acquired by Pharmacia AB of Upsala, Sweden. The company is renamed Pharmacia Diagnostics, Inc.  
  1991  
  Pharmacia Diagnostics sells the Clinical Chemistry and Centrifuge business to Alfa Schiapparelli Wassermann. The company is renamed Schiapparelli Biosystems, Inc.  
  1993  
  ACE, a discrete, random access centrifugal clinical chemistry system is launched. It is the first system of its kind to incorporate CLIA '88 compliant features.  
  1997  
  SMART CONSOLE (PC) control system introduced for KII centrifuge technology.  
  1998  
  NExCT a clinical chemistry system is launched. It is designed for lower volume labs as the ideal balance of low cost and high quality.  
  1999  
  Launched the SmartConsole control system for automated process operations incorporating distinctive features such as batch control, data recording, and safety monitoring with KII ultracentrifuge technology.  
  2000  
  Launch of Pilot System KII for research scale and pilot plant processes with linear scale capabilities, and SmartSystem KII for large volume production applications.  
  Initiated Genomics program for value-added healthcare products capitalizing on the global human genome effort.  
  2001  
  Company name changed to Alfa Wassermann, Inc. in conjunction with global alignment of all divisions with parent company.  
  Move to new headquarters in West Caldwell, New Jersey.  
  2002  
  Alfa Wassermann receives the NorthFace Scoreboard Award SM for customer excellence from the Omega Management Group Corp.  
  2003  
  Alfa Wassermann, Inc. receives ISO 9001:2000 Certificate.  
  Alfa Wassermann receives the NorthFace Scoreboard Award SM for customer excellence from the Omega Management Group Corp for the second consecutive year.  
  Creation of development unit for small scale ultracentrifugation technology.  
  2004  
  Alfa Wassermann launches the ACE Alera® clinical chemistry system.  
  Alfa Wassermann receives the NorthFace ScoreBoard Award SM for customer excellence from the Omega Management Group Corp for the third consecutive year.
 
 
  2005  
  Alfa Wassermann receives the NorthFace Score Board Award SM for customer excellence from the Omega Management Group Corp for the fourth consecutive year.  
  2006  
  Alfa Wassermann receives the NorthFace Score Board Award SM for customer excellence from the Omega Management Group Corp for the fifth consecutive year.  
  2007  
  Alfa Wassermann receives the NorthFace Score Board Award SM for customer excellence from the Omega Management Group Corp for the sixth consecutive year.

Launch of AW Promatix 1000™ BioProcessing System for developing separation and purification protocols directly transferable to production.
 
 
  2008  
  Launch of eSeries ultracentrifuges with electric drive, PLC control and reduced footprint.  
  Introduction of Starlyte™ V, the 5 parameter ISE Analyzer, for the international market. 

Alfa Wassermann receives the NorthFace Score Board Award SM for customer excellence from the Omega Management Group Corp for the seventh consecutive year.
 
 
  2009  
  Alfa Wassermann, Inc. receives ISO 9001:2008 Certificate.

Alfa Wassermann receives the NorthFace Score Board Award SM for customer excellence from the Omega Management Group Corp for the eighth consecutive year.
 
 
  2010  
  Alfa Wassermann receives the NorthFace Score Board Award SM for customer excellence from the Omega Management Group Corp for the ninth consecutive year.
 
 
  2011  
  Alfa Wassermann receives the NorthFace Score Board Award SM for customer excellence from the Omega Management Group Corp for the tenth consecutive year.
 
 
  2012  
  Alfa Wassermann launches the ACE Axcel™ clinical chemistry system.

Alfa Wassermann receives the NorthFace Score Board Award SM for customer excellence from the Omega Management Group Corp for the eleventh consecutive year.
 
 
  2013  
  Alfa Wassermann receives the NorthFace Score Board Award SM for customer excellence from the Omega Management Group Corp for the twelfth consecutive year.
 
 
 
 
 
 
Diagnostic Technologies
Separation Technologies
 
All Rights Reserved. Copyright 2014

| Directions | Email this page Sitemap | Terms of use | Privacy policy
Follow us:   Google+ Logo   LinkedIn Logo   YouTube Logo   Facebook Logo

McAfee SECURE sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams